Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,447,941
  • Shares Outstanding, K 30,890
  • Annual Sales, $ 12,730 K
  • Annual Income, $ -295,160 K
  • 60-Month Beta 2.13
  • Price/Sales 16.50
  • Price/Cash Flow N/A
  • Price/Book 4.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.57
  • Number of Estimates 9
  • High Estimate -0.12
  • Low Estimate -1.32
  • Prior Year -2.35
  • Growth Rate Est. (year over year) +75.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
99.00 +12.75%
on 12/30/19
122.69 -9.02%
on 01/21/20
+11.01 (+10.94%)
since 12/27/19
3-Month
95.71 +16.62%
on 11/26/19
140.68 -20.66%
on 11/05/19
-23.89 (-17.63%)
since 10/25/19
52-Week
95.71 +16.62%
on 11/26/19
196.00 -43.05%
on 05/07/19
-26.94 (-19.44%)
since 01/25/19

Most Recent Stories

More News
GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know

GW Pharmaceuticals PLC (GWPH) closed the most recent trading day at $118.97, moving -0.13% from the previous trading session.

GWPH : 111.62 (-2.52%)
New Records Ahead of New Trade Deal and New Earnings Season

New Records Ahead of New Trade Deal and New Earnings Season

CZZ : 21.48 (-5.37%)
MLCO : 20.12 (-5.27%)
TGT : 115.78 (+1.28%)
PLAB : 13.85 (-4.22%)
BERY : 46.10 (+0.13%)
CMC : 21.18 (-1.67%)
GPK : 16.42 (-0.06%)
MTDR : 15.27 (-3.35%)
HSTM : 26.02 (-0.46%)
SVMK : 18.05 (-2.96%)
CGC : 21.56 (-4.81%)
TLRY : 18.56 (-6.03%)
GWPH : 111.62 (-2.52%)
Legal Marijuana Market 2020 Analysis Focusing On Top Companies- Aurora Cannabis, Maricann Group,; GW Pharmaceuticals, plc.; Aphria

ACB.TO : 2.48 (-4.62%)
GWPH : 111.62 (-2.52%)
MRRCF : 0.0139 (+0.72%)
It's the Roaring 20's, Here's our Resolutions

2020 is already a big year, we've got a presidential election, impeachment and Iranian incident. How's this going to effect our trading? It won't.

GOOGL : 1,431.73 (-2.35%)
SQ : 71.05 (-0.13%)
BA : 316.60 (-2.00%)
GWPH : 111.62 (-2.52%)
Ride the Cannabis Wave With These 3 Stocks

Here we discuss three best stocks in the emerging cannabis space.

GWPH : 111.62 (-2.52%)
ZYNE : 5.22 (-2.97%)
TLRY : 18.56 (-6.03%)
CRON : 7.25 (-4.35%)
CGC : 21.56 (-4.81%)
APHA : 4.85 (-7.97%)
The Zacks Analyst Blog Highlights: Innovative Industrial Properties, Aphria, Square and GW Pharmaceuticals

The Zacks Analyst Blog Highlights: Innovative Industrial Properties, Aphria, Square and GW Pharmaceuticals

SQ : 71.05 (-0.13%)
GWPH : 111.62 (-2.52%)
IIPR : 84.97 (+5.21%)
APHA : 4.85 (-7.97%)
4 Marijuana Stocks to Play the Green Rush in 2020

Marijuana legalization has started to ramp-up in several U.S. states. What's more, legalization of marijuana in the state of Illinois in January could bring positive tidings for the marijuana industry....

SQ : 71.05 (-0.13%)
GWPH : 111.62 (-2.52%)
IIPR : 84.97 (+5.21%)
APHA : 4.85 (-7.97%)
Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX(R) (cannabidiol) in Patients with Tuberous Sclerosis Complex (TSC) at the American Epilepsy Society Annual Meeting

GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences, today...

GWPH : 111.62 (-2.52%)
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX(R) (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting

GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences announced...

GWPH : 111.62 (-2.52%)
Marijuana ETFs Bounce Back: Can the Rally Last?

Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.

TSLA : 558.02 (-1.20%)
AAPL : 308.95 (-2.94%)
GWPH : 111.62 (-2.52%)
IIPR : 84.97 (+5.21%)
CGC : 21.56 (-4.81%)
APHA : 4.85 (-7.97%)
TLRY : 18.56 (-6.03%)
ACB : 1.89 (-5.03%)
CRON : 7.25 (-4.35%)
THCX : 12.39 (-4.10%)
YOLO : 11.75 (-2.16%)
TOKE : 15.15 (-3.19%)
CNBS : 12.96 (-3.41%)
P : 8.38 (-1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade GWPH with:

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

2nd Resistance Point 116.40
1st Resistance Point 114.01
Last Price 111.62
1st Support Level 109.25
2nd Support Level 106.88

See More

52-Week High 196.00
Fibonacci 61.8% 157.69
Fibonacci 50% 145.85
Fibonacci 38.2% 134.02
Last Price 111.62
52-Week Low 95.71

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar